Phase II evaluation of doxorubicin plus amiodarone in advanced hepatocarcinoma.
作者信息
Chauffert B, Seitz J F, Bedenne L, Renard P, Conroy T, Rougier P
出版信息
Gastroenterol Clin Biol. 1991;15(10):774-5.
PMID:1667769
Abstract
摘要
相似文献
1
Phase II evaluation of doxorubicin plus amiodarone in advanced hepatocarcinoma.阿霉素联合胺碘酮治疗晚期肝癌的II期评估
Gastroenterol Clin Biol. 1991;15(10):774-5.
2
[Advanced hepatocellular carcinoma: value of systemic chemotherapy combining adriamycin, amiodarone and 5-fluorouracil].
Gastroenterol Clin Biol. 1989 Oct;13(10):845-6.
3
Adriamycin and 5-fluorouracil in the treatment of advanced hepatoma: a Southwest Oncology Group study.阿霉素与5-氟尿嘧啶治疗晚期肝癌：西南肿瘤协作组的一项研究
Cancer Treat Rep. 1977 Nov;61(8):1595-7.
4
[Treatment of hepatocellular carcinoma with adriamycin. Phase II clinical trial].[阿霉素治疗肝细胞癌。II期临床试验]
Gastroenterol Clin Biol. 1984 Aug-Sep;8(8-9):679-80.
5
Phase II trial of epirubicin in hepatoma.
Cancer Treat Rep. 1986 Aug;70(8):1035-6.
6
Phase II evaluation of doxorubicin plus bleomycin in hepatocellular carcinoma: a Southeastern Cancer Study Group trial.阿霉素联合博来霉素治疗肝细胞癌的II期评估：一项东南癌症研究组试验
Cancer Treat Rep. 1984 Dec;68(12):1517-8.
7
Adriamycin therapy in American patients with hepatocellular carcinoma.阿霉素对美国肝细胞癌患者的治疗
Cancer Treat Rep. 1977 Oct;61(7):1385-7.
8
[Hepatocellular carcinoma with cirrhosis: treatment with doxorubicin. Phase II evaluation].[伴有肝硬化的肝细胞癌：阿霉素治疗。II期评估]
Bull Cancer. 1984;71(5):442-5.
9
Pilot study with pegylated liposomal doxorubicin for advanced or unresectable hepatocellular carcinoma.聚乙二醇化脂质体阿霉素治疗晚期或不可切除肝细胞癌的初步研究。
Br J Cancer. 2001 Dec 14;85(12):1850-2. doi: 10.1054/bjoc.2001.2149.
10
A controlled study of intravenous doxorubicin versus oral tegafur in patients with hepatocellular carcinoma.一项关于静脉注射阿霉素与口服替加氟治疗肝细胞癌患者的对照研究。
Nihon Gan Chiryo Gakkai Shi. 1985 Apr 20;20(3):556-61.
Zotero 插件